Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0006599905
Thu, 24.04.2025
Merck KGaA
Darmstadt, April 24, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms late-stage discussions with SpringWorks Therapeutics, Inc. on a potential acquisition. The parties are in discussion on the basis of a price of around USD 47 per share. Merck notes that no final decision has been taken and no legally binding agreement has been ent [ … ]
Mon, 10.02.2025
Merck KGaA
Darmstadt, February 10, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms advanced discussions with Springworks Therapeutics, Inc. Merck also confirms that no legally binding agreement has been entered into. There is no certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met.
End of insid [ … ]